New York, New York (PRWEB) May 25, 2013
Pradaxa lawsuits filed on behalf of patients who allegedly suffered serious, life-threatening episodes of internal bleeding while using the blood thinner continue to mount in a federal litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to a posting on the Court’s website, 818 Pradaxa side effect claims had been filed in the litigation as of May 24, 2013. That’s up from 705 claims reported by the Court on May 15th. ( In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
“We are not surprised that the Pradaxa lawsuits filed in this litigation are increasing at such a rapid rate. Our Firm receives inquiries on a regular basis from Pradaxa patients who have allegedly suffered serious instances of internal bleeding,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free Pradaxa side effect lawsuit evaluations to anyone who suffered internal bleeding while using the blood thinner.
Pradaxa Side Effects
Plaintiffs with claims pending in the Pradaxa side effect litigation allege that Boehringer Ingelheim failed to adequately warn that there is no readily-available antidote for internal bleeding that is sometimes associated with use of the blood thinner. According to a Bloomberg.com report published in December 2012, regulators in several countries have issued alerts regarding Pradaxa’s potential to cause dangerous internal bleeding in some patients.* Pradaxa was supposed to be an improvement over warfarin, a decades old blood thinner. However, warfarin bleeding can be stopped via the administration of vitamin K, while dialysis is the only available treatment for this Pradaxa side effect. However, research published In May 2012 in the Journal of Neurosurgery indicated that dialysis is risky and may not be administered in enough time to stop Pradaxa bleeding.**
Since the publication of that study, additional research has indicated that Pradaxa bleeding is far more dangerous than the hemorrhaging that sometimes occurs with warfarin. In January, for example, a study of FDA hemorrhage cases published in the Institute for Safe Medication Practice’s QuarterWatch report found that Pradaxa patients who experienced internal bleeding were 5 times more likely to die in comparison to warfarin patients who suffered bleeding.*** On May 1st, the same journal published a study that showed head trauma victims were more likely to die from brain bleeding if they had been using Pradaxa compared to those taking the older blood thinner.****
Alleged victims of Pradaxa side effects may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Additional information regarding Pradaxa bleeding is available at Bernstein Liebhard LLP’s website. To arrange for a free Pradaxa lawsuit consultation, please call 800-511-5092 today.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-lawsuit/prweb10770330.htm.
Copyright©2012 Vocus, Inc.
All rights reserved